30010136|t|Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
30010136|a|Alzheimer's disease (AD) is a neurodegenerative disease pathologically characterized by extracellular amyloid-beta (Abeta) deposits and intracellular neurofibrillary tangles (NFT) in many brain regions. NFT are primarily composed of hyperphosphorylated tau protein (p-Tau). Abeta and p-Tau are two major pathogenic molecules with tau acting downstream to Abeta to induce neuronal degeneration. In this study, we investigated whether Ginkgo biloba extract EGb 761 reduces cerebral p-Tau level and prevents AD pathogenesis. Human P301S tau mutant-transgenic mice were fed with EGb 761, added to the regular diet for 2 or 5 months. We observed that treatment with EGb 761 for 5 months significantly improved the cognitive function of mice, attenuated the loss of synaptophysin and recovered the phosphorylation of CREB in the mouse brain. Treatment with EGb 761 for 5 but not 2 months also decreased p-Tau protein amount and shifted microglial pro-inflammatory to anti-inflammatory activation in the brain. As potential therapeutic mechanisms, we demonstrated that treatment with EGb 761, especially the components of ginkgolide A, bilobalide, and flavonoids, but not with purified ginkgolide B or C, increased autophagic activity and degradation of p-Tau in lysosomes of neurons. Inhibiting ATG5 function or treating cells with Bafilomycin B1 abolished EGb 761-enhanced degradation of p-Tau in cultured neurons. Additionally, we observed that 5- instead of 2-month-treatment with EGb 761 inhibited the activity of p38-MAPK and GSK-3beta. Therefore, long-term treatment with Ginkgo biloba extract EGb 761, a clinically available and well-tolerated herbal medication, ameliorates AD pathology through mechanisms against multiple AD pathogenic processes.
30010136	0	29	Ginkgo biloba Extract EGb 761	Chemical	-
30010136	137	140	Tau	Gene	4137
30010136	152	156	Mice	Species	10090
30010136	179	198	Alzheimer's disease	Disease	MESH:D000544
30010136	200	202	AD	Disease	MESH:D000544
30010136	209	234	neurodegenerative disease	Disease	MESH:D019636
30010136	281	293	amyloid-beta	Gene	351
30010136	295	300	Abeta	Gene	351
30010136	329	352	neurofibrillary tangles	Disease	MESH:D055956
30010136	354	357	NFT	Disease	MESH:D055956
30010136	382	385	NFT	Disease	MESH:D055956
30010136	453	458	Abeta	Gene	11820
30010136	509	512	tau	Gene	4137
30010136	534	539	Abeta	Gene	351
30010136	550	571	neuronal degeneration	Disease	MESH:D009410
30010136	612	641	Ginkgo biloba extract EGb 761	Chemical	-
30010136	684	686	AD	Disease	MESH:D000544
30010136	701	706	Human	Species	9606
30010136	707	712	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
30010136	713	716	tau	Gene	4137
30010136	735	739	mice	Species	10090
30010136	910	914	mice	Species	10090
30010136	939	952	synaptophysin	Gene	20977
30010136	990	994	CREB	Gene	12912
30010136	1002	1007	mouse	Species	10090
30010136	1124	1136	inflammatory	Disease	MESH:D007249
30010136	1145	1157	inflammatory	Disease	MESH:D007249
30010136	1294	1306	ginkgolide A	Chemical	MESH:C477042
30010136	1308	1318	bilobalide	Chemical	MESH:C073710
30010136	1324	1334	flavonoids	Chemical	MESH:D005419
30010136	1358	1375	ginkgolide B or C	Chemical	-
30010136	1468	1472	ATG5	Gene	11793
30010136	1505	1519	Bafilomycin B1	Chemical	MESH:C052501
30010136	1691	1699	p38-MAPK	Gene	26416
30010136	1704	1713	GSK-3beta	Gene	56637
30010136	1751	1780	Ginkgo biloba extract EGb 761	Chemical	-
30010136	1855	1857	AD	Disease	MESH:D000544
30010136	1904	1906	AD	Disease	MESH:D000544
30010136	Positive_Correlation	MESH:D009410	11820
30010136	Association	MESH:D000544	351
30010136	Association	351	4137
30010136	Positive_Correlation	MESH:D009410	351
30010136	Association	MESH:D009410	4137

